What is Behavioral Diagnostics?
Behavioral Diagnostics is a healthcare innovator focused on the early detection of substance addiction and cancer development. Leveraging advanced epigenetic methods and artificial intelligence, the company offers precise risk assessment tools such as the Lung CA Screening, Smoke Signature, and Alcohol Signature tests. Their solutions cater to healthcare providers, insurers, employers, and patients, aiming to improve health outcomes through proactive and actionable insights. The company's commitment to revolutionizing cancer care through early detection and prevention strategies positions it as a key player in the health technology sector.
How much funding has Behavioral Diagnostics raised?
Behavioral Diagnostics has raised a total of $85K across 1 funding round:
Debt
$85K
Debt (2021): $85K with participation from PPP
What's next for Behavioral Diagnostics?
With significant Series B/C stage backing, Behavioral Diagnostics is poised for accelerated growth and market penetration. The recent influx of expansion capital is expected to fuel further research and development, enhance product commercialization, and broaden the company's reach across its target markets. This strategic investment will likely enable Behavioral Diagnostics to scale its operations, refine its AI-driven diagnostic platforms, and solidify its position as a leader in predictive healthcare solutions.
See full Behavioral Diagnostics company page
